Your search returned 2 results.

Results
	1.	A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits. [electronic resource] by Anil, Tharappel M Dandu, Anilkumar Harsha, KrishnaReddy Singh, Jaideep Shree, Nitya Kumar, Venkatesh Satish Lakshmi, Mudigere N Sunil, Venkategowda Harish, Chandrashekaran Balamurali, Gundalmandikal V Naveen Kumar, Baisani S Gopala, Aralakuppe S Pratibha, Shivakumar Sadasivuni, ManojKumar Anup, Mammen O Moolemath, Yoganand Venkataranganna, Marikunte V Jagannath, Madanahalli R Somesh, Baggavalli P Producer: 20150331 In: BMC pharmacology & toxicology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models. [electronic resource] by Sadasivuni, Manoj Kumar Reddy, Bobbili Madhusudhan Singh, Jaideep Anup, Mammen O Sunil, Venkategowda Lakshmi, Mudigere N Yogeshwari, Sivakumaran Chacko, Suni K Pooja, Talanki Lokesh Dandu, Anilkumar Harish, Chandrashekaran Gopala, Aralakuppe S Pratibha, Shivakumar Naveenkumar, Baisani S Pallavi, Puttrevana M Verma, Mahesh Kumar Moolemath, Yoganand Somesh, Baggavalli P Venkataranganna, Marikunte V Jagannath, Madanahalli R Producer: 20140821 In: Diabetology & metabolic syndrome vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)